Coloplast A/S (OTCMKTS:CLPBY) Shares Gap Up – Time to Buy?

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY)’s share price gapped up prior to trading on Monday . The stock had previously closed at $6.88, but opened at $7.16. Coloplast A/S shares last traded at $7.19, with a volume of 11,728 shares trading hands.

Analysts Set New Price Targets

Separately, Kepler Capital Markets raised shares of Coloplast A/S to a “strong-buy” rating in a research report on Wednesday, May 20th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold”.

Coloplast A/S Stock Performance

The firm has a market capitalization of $16.36 billion, a price-to-earnings ratio of 38.21, a PEG ratio of 2.80 and a beta of 0.13. The firm has a 50 day moving average price of $6.35 and a 200-day moving average price of $6.62. The company has a debt-to-equity ratio of 1.66, a current ratio of 1.75 and a quick ratio of 1.09.

Coloplast A/S (OTCMKTS:CLPBY) last released its earnings results on Tuesday, August 18th. The company reported $0.10 EPS for the quarter, hitting the consensus estimate of $0.10. Coloplast A/S had a return on equity of 38.81% and a net margin of 9.68%.The firm had revenue of $1.14 billion during the quarter, compared to analysts’ expectations of $1.11 billion. As a group, sell-side analysts expect that Coloplast A/S Sponsored ADR will post 0.39 earnings per share for the current fiscal year.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.